future profitability, page-4

Up until recently, GTG held approx 70-75% of Immunaid..

Following recent round 1 Immunaid capital raise of 1M and a restructure of shareholders and the board, GTG's stake is now approx 40-45% (apologies for approximates but I dont have actual info with me atm).....

This has and will now allow Immunaid to spread its wings (independantly of GTG) NOW, and take control of its own destiny.

I expect there will be a Round 2 raise in the near the future (at much higher prices p/share) and I will bet it has already been oversubscribed and committed to by those who are aware just how powerful Immunaid is, and what it will become.

I have previously posted comments and details re Immunaid etc which you can read if interested.

GL fellow Geneies....(we wont need luck) !!